🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
March 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — March 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(2002)
All (2002)
Buys (178)
Sells (1824)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
THERMO FISHER SCIENTIFIC INC.
(TMO)
CASPER MARC N
— Director
Mar 5, 2026
Sale
Shares
214
Price
$511.78
Total Value
$109.52K
Shares Held After
127,474
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
THERMO FISHER SCIENTIFIC INC.
(TMO)
CASPER MARC N
— Director
Mar 5, 2026
Sale
Shares
99
Price
$509.66
Total Value
$50.46K
Shares Held After
127,688
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
THERMO FISHER SCIENTIFIC INC.
(TMO)
CASPER MARC N
— Director
Mar 5, 2026
Sale
Shares
58
Price
$507.54
Total Value
$29.44K
Shares Held After
127,787
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
THERMO FISHER SCIENTIFIC INC.
(TMO)
CASPER MARC N
— Director
Mar 5, 2026
Sale
Shares
60
Price
$505.76
Total Value
$30.35K
Shares Held After
127,845
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
THERMO FISHER SCIENTIFIC INC.
(TMO)
CASPER MARC N
— Director
Mar 5, 2026
Sale
Shares
20
Price
$503.66
Total Value
$10.07K
Shares Held After
127,905
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AGIOS PHARMACEUTICALS, INC.
(AGIO)
Viswanadhan Krishnan
— Chief Corp Dev & Strategy
Mar 5, 2026
Sale
Shares
2,959
Price
$27.80
Total Value
$82.26K
Shares Held After
5,141
% of Holdings
36.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Almstead Neil Gregory
— CHIEF TECHNICAL OPS OFFICER
Mar 5, 2026
Sale
Shares
3,989
Price
$63.38
Total Value
$252.82K
Shares Held After
2,737
% of Holdings
59.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VEEVA SYSTEMS INC
(VEEV)
Schwenger Thomas D.
— Pres. & Chief Customer Officer
Mar 5, 2026
Sale
Shares
1,000
Price
$200.00
Total Value
$200.00K
Shares Held After
22,204
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Metagenomi Therapeutics, Inc.
(MGX)
Wapnick Pamela
— Chief Financial Officer
Mar 5, 2026
Sale
Shares
1,581
Price
$1.60
Total Value
$2.53K
Shares Held After
187,375
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Xencor Inc
(XNCR)
Dahiyat Bassil I
— Director
Mar 5, 2026
Sale
Shares
14,870
Price
$11.25
Total Value
$167.22K
Shares Held After
552,922
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Fox Christine
— EVP, U.S. Commercial
Mar 5, 2026
Sale
Shares
7,924
Price
$31.67
Total Value
$250.94K
Shares Held After
84,905
% of Holdings
8.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Okey Stephanie
— Director
Mar 5, 2026
Sale
Shares
6,333
Price
$63.38
Total Value
$401.39K
Shares Held After
8,000
% of Holdings
44.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Xencor Inc
(XNCR)
Eckert Celia
— SVP, GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
3,244
Price
$11.25
Total Value
$36.48K
Shares Held After
78,685
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Savage Brian
— Interim Chief Legal Officer
Mar 5, 2026
Sale
Shares
1,127
Price
$31.67
Total Value
$35.69K
Shares Held After
10,914
% of Holdings
9.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Metagenomi Therapeutics, Inc.
(MGX)
Irish Jian
— Director
Mar 5, 2026
Sale
Shares
1,607
Price
$1.60
Total Value
$2.57K
Shares Held After
333,770
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Xencor Inc
(XNCR)
Cornelissen Bart Jan
— SR. VICE PRESIDENT & CFO
Mar 5, 2026
Sale
Shares
2,517
Price
$11.25
Total Value
$28.30K
Shares Held After
79,397
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Shields Matthew
— EVP, Global Operations
Mar 5, 2026
Sale
Shares
17,295
Price
$31.67
Total Value
$547.70K
Shares Held After
9,989
% of Holdings
63.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Jover Placid
— See "Remarks"
Mar 5, 2026
Sale
Shares
14,150
Price
$31.67
Total Value
$448.11K
Shares Held After
6,774
% of Holdings
67.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Hughes Eric A
— See "Remarks"
Mar 5, 2026
Sale
Shares
9,533
Price
$31.67
Total Value
$301.89K
Shares Held After
107,711
% of Holdings
8.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Xencor Inc
(XNCR)
Desjarlais John R
— SR. VICE PRESIDENT & CSO
Mar 5, 2026
Sale
Shares
4,118
Price
$11.25
Total Value
$46.31K
Shares Held After
266,333
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Daniell Richard
— EVP, Europe Commercial
Mar 5, 2026
Sale
Shares
17,295
Price
$31.67
Total Value
$547.70K
Shares Held After
85,755
% of Holdings
16.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Metagenomi Therapeutics, Inc.
(MGX)
Wein Matthew
— Title: General Counsel, Compliance Officer and Corporate Secretary
Mar 5, 2026
Sale
Shares
482
Price
$1.60
Total Value
$771.20
Shares Held After
114,549
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
Cole G Bradley
— Director
Mar 5, 2026
Sale
Shares
2,655
Price
$28.51
Total Value
$75.69K
Shares Held After
19,309
% of Holdings
12.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
Cole G Bradley
— Director
Mar 5, 2026
Sale
Shares
4,748
Price
$28.44
Total Value
$135.03K
Shares Held After
21,964
% of Holdings
17.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Gault Cheryl
— Chief Operating Officer
Mar 5, 2026
Sale
Shares
2,014
Price
$28.93
Total Value
$58.27K
Shares Held After
169,914
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Francis Richard D
— President and CEO
Mar 5, 2026
Sale
Shares
20,025
Price
$31.67
Total Value
$634.16K
Shares Held After
1,170,639
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 5, 2026
Sale
Shares
587
Price
$487.98
Total Value
$286.45K
Shares Held After
130
% of Holdings
81.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 5, 2026
Sale
Shares
1,199
Price
$487.02
Total Value
$583.94K
Shares Held After
717
% of Holdings
62.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 5, 2026
Sale
Shares
798
Price
$486.20
Total Value
$387.99K
Shares Held After
1,916
% of Holdings
29.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 5, 2026
Sale
Shares
2,625
Price
$485.00
Total Value
$1.27M
Shares Held After
2,714
% of Holdings
49.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 5, 2026
Sale
Shares
1,728
Price
$484.05
Total Value
$836.44K
Shares Held After
5,339
% of Holdings
24.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 5, 2026
Sale
Shares
1,293
Price
$482.93
Total Value
$624.42K
Shares Held After
7,067
% of Holdings
15.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 5, 2026
Sale
Shares
510
Price
$482.05
Total Value
$245.84K
Shares Held After
8,360
% of Holdings
5.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 5, 2026
Sale
Shares
481
Price
$480.56
Total Value
$231.15K
Shares Held After
8,870
% of Holdings
5.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 5, 2026
Sale
Shares
279
Price
$479.89
Total Value
$133.89K
Shares Held After
9,351
% of Holdings
2.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
Stokes Frank
— Chief Financial Officer
Mar 5, 2026
Sale
Shares
6,001
Price
$27.98
Total Value
$167.91K
Shares Held After
60,085
% of Holdings
9.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SUPERNUS PHARMACEUTICALS, INC.
(SUPN)
GEMAYEL GEORGES
— Director
Mar 5, 2026
Sale
Shares
10,000
Price
$53.71
Total Value
$537.10K
Shares Held After
28,159
% of Holdings
26.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Quantum-Si Inc
(QSI)
Kummeth Charles R.
— Director
Mar 5, 2026
Purchase
Shares
500,000
Price
$0.92
Total Value
$459.80K
Shares Held After
855,000
% of Holdings
58.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TANDEM DIABETES CARE INC
(TNDM)
Novara Mark David
— EVP & CHIEF COMMERCIAL OFFICER
Mar 5, 2026
Sale
Shares
2
Price
$22.81
Total Value
$45.62
Shares Held After
35,969
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Quantum-Si Inc
(QSI)
Dowdy Paula
— Director
Mar 5, 2026
Purchase
Shares
109,890
Price
$0.95
Total Value
$104.45K
Shares Held After
269,107
% of Holdings
40.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Golden Lee Scott
— EVP & CHIEF MEDICAL OFFICER
Mar 5, 2026
Sale
Shares
10,000
Price
$63.38
Total Value
$633.80K
Shares Held After
79,944
% of Holdings
11.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Entera Bio Ltd.
(ENTX)
Ellis Sean
— Director
Mar 5, 2026
Purchase
Shares
10,000
Price
$1.23
Total Value
$12.30K
Shares Held After
188,098
% of Holdings
5.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ADMA BIOLOGICS, INC.
(ADMA)
ELMS STEVE
— Director
Mar 5, 2026
Purchase
Shares
7,000
Price
$15.67
Total Value
$109.69K
Shares Held After
2,038,730
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alphatec Holdings, Inc.
(ATEC)
Marshall Tyson Eliot
— GENERAL COUNSEL & CORP. SEC.
Mar 5, 2026
Sale
Shares
88,835
Price
$12.49
Total Value
$1.11M
Shares Held After
559,459
% of Holdings
13.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cullinan Therapeutics, Inc.
(CGEM)
Michaelson Jennifer
— Chief Scientific Officer
Mar 5, 2026
Sale
Shares
8,000
Price
$15.68
Total Value
$125.44K
Shares Held After
170,844
% of Holdings
4.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BIOLIFE SOLUTIONS INC
(BLFS)
Foster Karen A.
— Chief Quality and Operations
Mar 5, 2026
Sale
Shares
96,923
Price
$20.15
Total Value
$1.95M
Shares Held After
113,742
% of Holdings
46.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
Hamilton James C
— Chief Medical Officer
Mar 5, 2026
Sale
Shares
10,000
Price
$64.19
Total Value
$641.90K
Shares Held After
236,958
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PROCEPT BioRobotics Corp
(PRCT)
Desai Antal Rohit
— Director
Mar 5, 2026
Purchase
Shares
24,748
Price
$26.41
Total Value
$653.53K
Shares Held After
167,246
% of Holdings
14.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PROCEPT BioRobotics Corp
(PRCT)
Desai Antal Rohit
— Director
Mar 5, 2026
Purchase
Shares
142,498
Price
$25.44
Total Value
$3.63M
Shares Held After
142,498
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surgery Partners, Inc.
(SGRY)
Webb William Trenton
— American Group President
Mar 5, 2026
Sale
Shares
1,794
Price
$13.86
Total Value
$24.86K
Shares Held After
72,455
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 1151–1200 of 2002 transactions (page 24 of 41)
Version: v26.3.33